In part 3 of this slideshow series, take a look back at the novel drugs and therapeutics approved by the FDA in 2023,1 including treatments for postpartum depression, relapsed or refractory multiple myeloma, and major depressive disorder.References1. Novel drug approvals for 2023. FDA. Reviewed November 28, 2023. Accessed November 28, 2023. https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-20232. FDA approves first […]
